Menu

CME Corner

 Decision Points in the Treatment of Psoriatic Arthritis

A 3-Part Series

Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. An estimated 7.5 million Americans have psoriasis, and an estimated 30% to 40% of individuals with psoriasis also develop PsA. Symptoms of PsA include fatigue, pain and inflammation in joints, and potentially progressive joint damage. Despite the availability of a variety of treatment options, many patients with PsA continue to experience suboptimal outcomes. These activites will examine recent clinical advances in the treatment of PsA and rapidly evolving standards of care.

Target audience:
Rheumatologists, dermatologists, and other clinicians who treat patients with PsA.

SERIES ACTIVITIES
newsletter Assessing Psoriatic Arthritis Severity, Setting Goals, and Monitoring Progress
Online Presentation
Start
newsletter

Improving Patient Satisfaction with Psoriatic Arthritis Treatment
Online Presentation

Start
newsletter Integrating Recently Approved Therapies into Psoriatic Arthritis Treatment Plans
Online Presentation
Start


Faculty
James J. Curran, MD
Professor of Medicine Department of Rheumatology
The University of Chicago School of Medicine
Chicago, IL

 

 

 

 

Main Menu
EDITOR'S PICKS